The activation of SIRT1 could effectively inhibit MAPK, NF-κB, and STAT3 phosphorylation, thereby decreasing the expression of downstream genes and secretion of inflammatory cytokines, eventually blocking the development of psoriasis. The gene discussed is NFKB1; the disease is psoriasis.